P1150: A PROSPECTIVE PHASE II CLINICAL TRIAL USING CHIDAMIDE, TISLELIZUMAB, AND PEGASPARGASE IN COMBINATION WITH RADIOTHERAPY AS FIRST-LINE TREATMENT IN STAGES I/II OF EXTRANODAL NK/T-CELL LYMPHOMA
Hui Zhou,
Yajun LI,
Ruolan Zeng,
Yizi He
Affiliations
Hui Zhou
1 Hunan Cancer Hospital, Department of Lymphoma and Hematology, Changsha, China
Yajun LI
1 Hunan Cancer Hospital, Department of Lymphoma and Hematology, Changsha, China
Ruolan Zeng
1 Hunan Cancer Hospital, Department of Lymphoma and Hematology, Changsha, China
Yizi He
1 Hunan Cancer Hospital, Department of Lymphoma and Hematology, Changsha, China
